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Concanavalin A-induced proliferation of rat T-lymphocytes is completely inhibited by lop5 M pyrazo- 
furin, a potent inhibitor of pyrimidine de novo synthesis, as ‘udged by cell viability and [3H]thymidine 
incorporation. Proliferation is completely restored by 5 X IO- 5’ ” M urtdme. Cytidine, deoxycytidine, deoxy- 
uridine and thymidine 10 x lop5 M each, fail to re-establish proliferation but produce an isotropic 
dilution of [3H]thymidine uptake in DNA. Bases (cytosine, uracil and thymine) neither restore prolifera- 
tion nor induce isotopic dilution. The unexpected inability of cytidine to reverse de novo pyrimidine 
synthesis inhibition suggests a lack of cytidine deaminase activity in rat T-lymphoc 
by a direct sensitive radioisotopic assay ( < 0.001 nmol . min-’ . lo- P 
tes. This is confirmed 
cells). 
Con A-stimulated T lymphocytes Pyrimidine de novo synthesis Pyrimidine salvage pathways 
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1. INTRODUCTION 
Inhibition of pyrimidine de novo biosynthesis in 
different malignant cell systems by pyrazofurin 
(PF), a potent inhibitor of orotidylate decarboxy- 
lase [ 1,2], could be reversed by addition of exogen- 
ous nucleosides. In every case, not only uridine 
(Urd) was effective but also cytidine (Cyd) [ 1,2] or 
the combination of deoxycytidine (dCyd) and de- 
oxyuridine (dUrd) [2]. 
Here, we used complete Freund’s adjuvant 
(CFA)-activated lymph nodes as a source of T 
lymphocytes [3] to study the different metabolic 
pathways of pyrimidine nucleotide biosynthesis in- 
volved in these cells. As found in other systems, 
con A-activated T cells’ proliferation was com- 
pletely inhibited in the presence of 10 -5 M PF. 
However, we found that only uridine could reverse 
such an inhibition. Furthermore, in the absence of 
PF, 3 nucleosides (cytidine, deoxycytidine and de- 
oxyuridine) which did not reverse PF inhibition, 
were able to provide an important decrease of 
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[3H]deoxythymidine (d[3H]Thd) incorporation into 
DNA, showing the importance of the different 
pyrimidine metabolism pathways in rat T lympho- 
cytes. 
2. MATERIALS 
Chemicals used included: pyrazofurin (4-hydro- 
xy-5-/?-D-ribofuranosylpyrazole-3-carboxamide), a 
gift from Dr Davis (Lilly Res. Lab., Indianapolis 
IN); pyrimidine bases and nucleosides from 
Boehringer (Mannheim); Bacto complete Freund’s 
adijuvant (CFA) from Difco Lab. (Detroit MI); 
[6- Hlthymidine (1 Ci/mmol), [U-‘4C]cytidine 
were purchased from CEA (Gifs/Yvette) and all 
other products as in (41. 
3. METHODS 
Three-months-old Sprague Dawley rats were in- 
jected twice in the hind footpads with CFA. Five 
days after the second injection, popliteal lymph 
nodes were aseptically removed and dissociated in 
the culture medium described below. After cell 
viability control, the cellular suspension was ad- 
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justed to lo6 cells/ml in Dulbecco’s medium modi- 
tied according to [5] and supplemented with 
33 mM Hepes, 10% foetal calf serum (FCS), pen- 
icillin (100 U/ml) and streptomycin (100 pg/ml). 
The cell suspension with or without con A (5 pg/ 
ml) was dispensed into 96-well microtiter plates 
(3040 Falcon Labware, Oxnard CA). PF (lop5 M 
final) and effecters were added at culture initia- 
tion. Each culture contained 1.8 x lo5 cells in 
0.2 ml final vol. After 48 h incubation at 37°C in 
5% CO2, cultures were pulsed for 18 h with 1 yCi/ 
well of d[3H]Thd. d[3H]Thd incorporation in DNA 
was then quantitated as in [6]. All assays were done 
in triplicate. Cultures were run in parallel to count 
the cells after the 3 days of culture. 
Cytidine deaminase activity was determined by 
radioisotopic assa 
tained 55 x 10 - Y. 
The reaction mixtures con- 
M Tris-HCl (pH 7.4) 210 X 
10e6 M [U-‘4C]cytidine and cell free extract in 
200 ~1 final vol. The reaction was run at 37°C. At 
various times, 50 ~1 samples were taken and the 
reaction was stopped by heating at 96°C for 2 min. 
Cytidine, uracil and uridine were separated by de- 
scending chromatography on Whatman CM82 pa- 
per in distilled water. Cytidine deaminase activity 
was calculated from the percentage of radioactivity 
appearing in uridine + uracillmin. The reaction 
was linear with time and cell-free extracts volume. 
The limit of detection of the method was 0.007 
nmol/min. HPLC analysis of foetal calf serum 
(FCS) was performed as in [7]. 
4. RESULTS 
4.1. PF inhibition of con A-stimulated T lympho- 
cytes proliferation 
Under our medium conditions, con A (5 pg/ml) 
induced a maximal lymph node T-cell prolifera- 
tion after 3 days of culture. This was estimated by 
the total number of cells (blasts represented 
- 100%) and the incorporation of d[3H]Thd in the 
acid-insoluble cell fraction. Such an activation was 
completely inhibited when PF was present at 10m5 
M, which was in our system the optimal inhibitory 
concentration (not shown). 
4.2. Reversion of PF inhibition by pyrimidine bases 
and nucleosides (fig.1) 
As in [ 1,2], uridine was able to reverse the inhib- 
itory action of PF. The blastogenesis was entirely 
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Fig.l. Incorporation of d[3H]Thd into the acid-insoluble 
material of con A-stimulated rat T lymphocytes cultured 
in DNA in the presence of con A alone 
in the presence of PF (10 -5 M) and pyrimidine bases 
and nucleosides: (o) uracil; (*) cytosine; (TV) thymine; 
(130 000-200 000 cpm). 
(0) uridine; (Q) cytidine; (.) deoxyuridine; (.) deoxy- 
cytidine; (m) thymidine. The conditions of culture, and 
the acid-insoluble material extraction are described in 
section 2. Each value is the mean of the results obtained 
in 4 separate experiments (the bars represent the SD). 
‘Control’ represents the value of d[ 3H]Thd incorporation 
restored by this nucleoside at a concentration of 
50 PM. We tested also the capacity of pyrimidine 
bases (cytosine, uracil and thymine) and nucleo- 
sides (cytidine, deoxyuridine and deoxythymidine) 
to restore proliferation. No effect was observed 
with any of these compounds over lo-500 PM. 
4.3. Effect of pyrimidine bases and nucleosides on 
d[‘H]Thd incorporation in DNA (Jig.2) 
Such a failure of pyrimidine bases and nucleo- 
sides (except uridine) to bypass PF inhibition of 
pyrimidine de novo biosynthesis apparently con- 
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Fig.2. d[sH]Thd incorporation into the acid-insoluble 
material of con A-stimulated rat T lymphocytes cultured 
in the presence of pyrimidine nucleosides. All assays 
were performed as in section 2 and without PF. Each 
value represents the mean of separate experiments (SD 
15%). ‘Control’ represents the value of d[3H]Thd incor- 
poration into DNA in the presence of con A alone 
(130 000-200 000 cpm). 
trasts with the effects of these compounds on 
d13H]Thd incorporation into DNA in the absence 
of PF. Thus dUrd, Cyd and dCyd gave a 50% de- 
crease of d[3H]Thd incorporation at < 100 PM. 
Surprisingly, uridine was less effective, 500 PM 
giving only a 25% decrease. In no case was any 
modification of the total number of blasts found, 
indicating that the effects observed were indeed an 
inhibition of d13H]Thd incorporation in DNA and 
not a toxic effect. It should also be noted that 
uridine by itself did not produce any enhancement 
of the cell proliferation. This was tested over lo- 
500 I_IM (not shown). 
4.4. Determination of cytidine deaminase activity 
Cytidine deaminase activity in unstimulated 
and con A-stimulated rat T lymphocytes was 
<O.OOl nmol. min-’ . 10 -’ cells (8 determina- 
tions). By contrast, an activity of 0.28 nmol . min-’ 
. lop6 cells (mean of 5 determinations) was found 
in unstimulated human peripheral lymphocytes. 
5. DISCUSSION 
Under our culture conditions when de novo bio- 
synthesis was inhibited, neither the medium we 
used (supplemented with 10% FCS which contains 
- 5 PM of uridine as estimated by HPLC dosage), 
nor nucleic acids degradation (in this type of lym- 
phocyte proliferation an important number of 
cells, principally B cells which are not con A-stim- 
ulated, die early) were sufficient to provide enough 
substrates to sustain an adequate salvage pathway. 
Therefore, we conclude that without any external 
addition, the con A-induced proliferation depends 
exclusively on the activity of pyrimidine de novo 
biosynthesis. Furthermore, when uridine is added 
to the medium, the absence of any increase in cell 
proliferation indicates that de novo pathway is 
able to provide a maximum response to mitogen. 
This is in contrast with the general assumption that 
most of the pyrimidine nucleotides are supplied 
through the salvage pathway in mitogen-stimulat- 
ed lymphocytes [8] and is most consistent with the 
findings [9] of a prominent role for the de novo 
biosynthesis. Conversely, the use of PF allowed us 
to estimate the activity of uridine salvage pathway 
alone. In the two cases studied we did not observe 
differences in blastogenesis. Our results indicate 
that both metabolic pathways (de novo synthesis 
and salvage pathway) are equally effective in pro- 
ducing maximal T-cell proliferation. 
The fact that among pyrimidine compounds, 
only uridine could reverse PF inhibition, permits 
an evaluation of the physiological importance of 
the different pyrimidine salvage pathways (lig.3). 
In our experiments, no effect was observed with 
cytidine, which contrast with the findings in other 
cell systems [ 1,2] where cytidine was as efficient as 
uridine to reverse PF inhibition. From that, it can 
be concluded that cytidine deaminase is not active 
in stimulated lymph-node rat T lymphocytes. This 
was confirmed by direct assay of enzymatic ac- 
tivity. Similarly, the lack of effect of uracil indi- 
cates that the cells cannot salvage uracil either by 
uracil-phosphoribosyltransferase or by uridine 
phosphorylase activities. Deoxycytidine and de- 
oxyuridine did not restore cell proliferation, which 
confirms the incapacity of the cells to salvage the 
base moiety of these nucleosides, and indicates 
that a transfer between ribose and deoxyribose 
does not operate among pyrimidine nucleosides. 
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Fig.3. Pyrimidine salvage pathways in eukaryotic cells: (1) pyrimidine nucleoside phosphorylases - thymidine phos- 
phorylase, EC 2.4.2.4; uridine phosphorylase, EC 2.4.2.3; (2) thymidine kinase, EC 2.7.1.2 1; (3) uridine-cytidine 
kinase, EC 2.7.1.48; (4) deoxycytidine kinase, EC 2.7.1.74; (5) 5’-pyrimidine nucleotidases - thymidylate 5’ phos- 
phatase, EC 3.1.3.35; (6) nucleoside kinases - nucleoside monophosphate kinase, EC 2.7.4.14; thymidylate kinase, EC 
2.7.4.9; nucleoside diphosphokinases, EC 2.7.4.6; (7) thymidylate synthase. EC 2.1.1 .b; (8) ribonucleoside diphospho- 
reductase, EC 1.17.4.1; (9) cytidine triphosphate synthetase, EC 6.3.4.2; (10) deoxycytidine monophosphate deaminase. 
EC 3.5.4.12; (11) cytidine deaminase, EC 3.5.4.5; (12) orotate phosphoribosyltransferase, EC 2.4.2.10. 
The inhibition by pyrimidine nucleosides of tri- 
tiated thymidine incorporation into DNA may be 
due to an interaction with thymidine transport 
through the plasma membrane, and/or with intra- 
cellular thymidine metabolism. Nucleoside trans- 
port in cultured cells is a controversial matter. 
From studies in various cell [lo] it was concluded 
that thymidine, deoxycytidine and uridine are 
transported by a single carrier. In contrast, in phy- 
tohemagglutinin stimulated pig lymphocytes, the 
thymidine transport system was reported different 
from that for uridine and that for deoxycytidine 
[ 11,121. If this was also the case for mitogen-stimu- 
lated rat lymphocytes, the effects we observed 
would be better explained by intracellular syn- 
thesis of thymidylate from non-radioactive nu- 
cleosides, and isotopic dilution of d[3H]Thd in thy- 
midine nucleotide pool(s), a mechanism similar to 
the deoxyuridine suppression of d[3H]Thd incor- 
poration in DNA in bone marrow cells 1131. This, 
and the results discussed above, suggest that cyti- 
dine and deoxycytidine if they cannot fulfil the 
pyrimidine requirements of the cells can however 
be salvaged by rat T lymphocytes by the sequential 
activity of the following enzymes: 
-for cytidine 
cytidine kinase -+ ribonucleoside diphosphate 
reductase + dCMP deaminase + thymidylate 
synthase 
-for deoxycytidine 
deoxycytidine kinase + dCMP deaminase + 
thymidylate synthase 
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